[On the differences of effect of atropine, scopolamine and some of their quaternary derivatives after subcutaneous and enteral administration with special reference to scopolamine-n-butylbromide].
D000818:Animals; D001158:Arteries; D001285:Atropine / Q000008:administration & dosage* / Q000633:toxicity; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D005753:Gastric Mucosa / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects; D007279:Injections, Subcutaneous; D007421:Intestine, Small / Q000187:drug effects; D007441:Intubation, Gastrointestinal; D008297:Male; D051379:Mice; D009132:Muscles / Q000494:pharmacology*; D009184:Mydriatics / Q000494:pharmacology*; D051381:Rats; D012601:Scopolamine / Q000008:administration & dosage* / Q000633:toxicity; D014326:Tropanes / Q000008:administration & dosage* / Q000633:toxicity; D001743:Urinary Bladder / Q000187:drug effects
D009184:Mydriatics; D014326:Tropanes; D001285:Atropine; D012601:Scopolamine
Uber wirkungsunterschiede von Atropin, Scopolamin und einigen ihrer quartären Derivate nach subcutaner und enteraler Gabe unter besonderer Berücksichtigung des Scopolamin-n-butylbromids.